atovaquone has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourigault, P; Higgins, GS; Macpherson, RE; McGowan, DR; Skwarski, M | 1 |
| Belcher, E; Buffa, FM; Bull, JA; Bulte, D; Campo, L; Chauhan, J; Chu, KY; Croal, PL; Derham, JL; Di Chiara, F; Ferencz, P; Flight, H; Folkes, LK; Gleeson, FV; Green, M; Harris, AL; Harris, BHL; Higgins, GS; Holmes, J; Macklin, PS; Macpherson, RE; McCole, M; McGowan, DR; McKenna, WG; O'Connor, JPB; O'Reilly, D; Prevo, R; Qi, C; Rodriguez-Berriguete, G; Skwarski, M; Stavroulias, D; Teoh, E | 1 |
2 other study(ies) available for atovaquone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients.
Topics: Atovaquone; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Humans; Hypoxia; Lung Neoplasms; Misonidazole; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.
Topics: Atovaquone; Carcinoma, Non-Small-Cell Lung; Energy Metabolism; Epithelial-Mesenchymal Transition; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mitochondria; Molecular Imaging; Oxidative Phosphorylation; Positron Emission Tomography Computed Tomography; STAT3 Transcription Factor; Tumor Hypoxia | 2021 |